APA

Corsi M. M., Ponti W., Ferrara F., Venditti A., Malavazos A., Ruscica M., Mihali D., Diana G. M., Paraboni L. & Bertelli A. A. E. (20031006). Nanomolar level of resveratrol (trans-3,5,4'-trihydroxystilbene) is required, but is not sufficient, to inhibit the growth of human monocytoid tumor cells through an apoptotic-like mechanism. : Drugs under experimental and clinical research.

Chicago

Corsi M M, Ponti W, Ferrara F, Venditti A, Malavazos A, Ruscica M, Mihali D, Diana G M, Paraboni L and Bertelli A A E. 20031006. Nanomolar level of resveratrol (trans-3,5,4'-trihydroxystilbene) is required, but is not sufficient, to inhibit the growth of human monocytoid tumor cells through an apoptotic-like mechanism. : Drugs under experimental and clinical research.

Harvard

Corsi M. M., Ponti W., Ferrara F., Venditti A., Malavazos A., Ruscica M., Mihali D., Diana G. M., Paraboni L. and Bertelli A. A. E. (20031006). Nanomolar level of resveratrol (trans-3,5,4'-trihydroxystilbene) is required, but is not sufficient, to inhibit the growth of human monocytoid tumor cells through an apoptotic-like mechanism. : Drugs under experimental and clinical research.

MLA

Corsi M M, Ponti W, Ferrara F, Venditti A, Malavazos A, Ruscica M, Mihali D, Diana G M, Paraboni L and Bertelli A A E. Nanomolar level of resveratrol (trans-3,5,4'-trihydroxystilbene) is required, but is not sufficient, to inhibit the growth of human monocytoid tumor cells through an apoptotic-like mechanism. : Drugs under experimental and clinical research. 20031006.